v3.26.1
Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) Unaudited - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Total revenue $ 11,273,837 $ 8,009,987 $ 20,429,495 $ 15,160,170
Total cost of goods sold (5,903,860) (4,455,502) (11,101,884) (8,241,938)
Gross profit 5,369,977 3,554,485 9,327,611 6,918,232
Operating expenses        
Amortization (Notes 9, 10) 65,650 107,927 156,812 212,911
General and administrative 4,318,584 2,678,372 7,930,407 5,210,626
Share-based compensation (Note 15) 149,087 336,825 304,081 1,772,735
Total operating expenses 4,533,321 3,123,124 8,391,300 7,196,272
Income (loss) from operations 836,656 431,361 936,311 (278,040)
Other income (expense)        
Interest expense (Note 11, 12) (429,240) (432,553) (979,220) (690,724)
Other income (expense) (116,128) (173,887) 49,140 623,069
Interest income 104,356 36,337 146,543 72,274
Unrealized gain (loss) on derivative liability (Note 12) 82,006 (2,892,027) 148,383 (27,654)
Realized gain on derivative liability (Note 12) 5,889,032 5,859,744
Unrealized loss on warrant asset (Note 6) (556,583) (168,162) (2,747,667) (1,340,654)
Unrealized gain (loss) on warrant liability (Note 12) (337,167) 433,547
Loss on equity investment in associate (Note 7) (193,593) (114,686) (293,250) (268,420)
Total other income (expense), net (1,446,349) 2,144,054 (3,242,524) 4,227,635
Income (loss) before income tax expense (609,693) 2,575,415 (2,306,213) 3,949,595
Income tax expense (Note 17) (871,331) (920,037) (1,388,202) (1,551,347)
Net income (loss) (1,481,024) 1,655,378 (3,694,415) 2,398,248
Other comprehensive income        
Currency translation adjustment (6,547) 1,285
Total comprehensive income (loss) $ (1,481,024) $ 1,648,831 $ (3,694,415) $ 2,399,533
Basic income (loss) per share $ (0.01) $ 0.01 $ (0.02) $ 0.01
Basic weighted average number of subordinate voting common shares outstanding 249,938,980 247,015,784 249,926,825 237,157,649
Diluted income (loss) per share (0.01) 0.01 (0.02) 0.01
Diluted weighted average number of subordinate voting common shares outstanding $ 249,938,980 $ 252,922,833 $ 249,926,825 $ 243,607,029
Net income (loss) for the period attributable to:        
Shareholders $ (1,692,836) $ 1,499,975 $ (4,395,053) $ 2,098,757
Non-controlling interest 211,812 155,403 700,638 299,491
Net income (loss) (1,481,024) 1,655,378 (3,694,415) 2,398,248
Total comprehensive income (loss) for the period attributable to:        
Shareholders (1,692,836) 1,322,312 (4,395,053) 2,100,042
Non-controlling interest 211,812 326,519 700,638 299,491
Total comprehensive income (loss) (1,481,024) 1,648,831 (3,694,415) 2,399,533
Product [Member]        
Total revenue 11,273,837 8,009,987 20,429,495 15,160,170
Cost of finished cannabis inventory sold [Member]        
Total cost of goods sold $ (5,903,860) $ (4,455,502) $ (11,101,884) $ (8,241,938)